<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Pan Afr Med J</journal-id>
      <journal-id journal-id-type="iso-abbrev">Pan Afr Med J</journal-id>
      <journal-id journal-id-type="publisher-id">PAMJ</journal-id>
      <journal-title-group>
        <journal-title>The Pan African Medical Journal</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1937-8688</issn>
      <publisher>
        <publisher-name>The African Field Epidemiology Network</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27800117</article-id>
      <article-id pub-id-type="pmc">5075454</article-id>
      <article-id pub-id-type="publisher-id">PAMJ-24-264</article-id>
      <article-id pub-id-type="doi">10.11604/pamj.2016.24.264.6670</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Myositis ossificans progressive: case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Talbi</surname>
            <given-names>Sofia</given-names>
          </name>
          <xref ref-type="aff" rid="aff0001">1</xref>
          <xref ref-type="corresp" rid="cor1">&amp;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aradoini</surname>
            <given-names>Nassira</given-names>
          </name>
          <xref ref-type="aff" rid="aff0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mezouar</surname>
            <given-names>Iman El</given-names>
          </name>
          <xref ref-type="aff" rid="aff0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Abourazzak</surname>
            <given-names>Fatima Ezzahra</given-names>
          </name>
          <xref ref-type="aff" rid="aff0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Harzy</surname>
            <given-names>Taoufik</given-names>
          </name>
          <xref ref-type="aff" rid="aff0001">1</xref>
        </contrib>
      </contrib-group>
      <aff id="aff0001"><label>1</label>Department of Rheumatology, University Hospital Hassan II, Fes, Morocco</aff>
      <author-notes>
        <corresp id="cor1"><label>&amp;</label>Corresponding author: Sofia Talbi, Department of Rheumatology, University Hospital Hassan II, Fes, Morocco</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>7</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>24</volume>
      <elocation-id>264</elocation-id>
      <history>
        <date date-type="received">
          <day>25</day>
          <month>3</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>10</day>
          <month>4</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Sofia Talbi et al.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/">
          <license-p>The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Myositis ossificans progressiva (MOP) is an autosomal dominant disorder. There is a progressive ectopic ossification and skeletal malformation, mainly in the connective tissue of muscle. The diagnosis is based on the clinical findings and radiological demonstration of the skeletal malformations. A 38-year-old female patient was admitted to our department with progressive increase of the thigh. Results of laboratory studies were normal. The radiography of the right thigh showed multiple intramuscular calcifications. Myositis ossificans progressiva should be diagnosed as early as possible and non-invasively, based upon history, clinical and radiological findings. Early and correct diagnosis is fundamental for indication of proper management of the disease.</p>
      </abstract>
      <kwd-group>
        <kwd>Myositis ossificans progressive</kwd>
        <kwd>ossification</kwd>
        <kwd>ectopic bone</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="sec1">
      <title>Introduction</title>
      <p>Myositis ossificans progressiva (MOP) is an autosomal dominant disorder. This disease is very rare with an incidence of less than 1 in 10,000,000 populations. There is a progressive ectopic ossification and skeletal malformation, mainly in the connective tissue of muscle. Muscles most often involved are brachialis, quadriceps femoris and adductor muscles of thigh. The diagnosis is based on the clinical findings and radiological demonstration of the skeletal malformations. Early and correct diagnosis is fundamental for indication of proper management of the disease. We report the case of a 38-year-old woman with clinical and radiological features of MOP.</p>
    </sec>
    <sec id="sec2">
      <title>Patient and observation</title>
      <p>A 38 -year-old female patient consulted at our department. She has no family or individual medical history. She has presented 3 years earlier, a progressive increase in thigh volume with functional disability. On the physical examination we have found a painless mass of the right thigh with hard consistency and neovascularization (<xref ref-type="fig" rid="f0001">Figure 1</xref>). Results of laboratory studies were normal: erythrocyte sedimentation rate (ESR) C-reactive protein (CRP) and calcium and phosphate levels. The radiography of the right thigh showed a large calcifications or ectopic bone of soft tissues (<xref ref-type="fig" rid="f0002">Figure 2</xref>). The magnetic resonance imaging (MRI) of the thigh has shown a significant increase of the right thigh muscles witha high signal intensity on T2- weighted images related tocalcification area. A muscle biopsy was done with immunohistological study and the result was in favor of myositis ossificans. Written informed consent was obtained from the patient&#x2019;s legal guardian for publication of the case.</p>
      <fig id="f0001" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Clinical aspect of thigh</p>
        </caption>
        <graphic xlink:href="PAMJ-24-264-g001"/>
      </fig>
      <fig id="f0002" orientation="portrait" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Radiography of the right thigh showed a large calcifications or ectopic bone of soft tissues</p>
        </caption>
        <graphic xlink:href="PAMJ-24-264-g002"/>
      </fig>
    </sec>
    <sec sec-type="discussion" id="sec3">
      <title>Discussion</title>
      <p>Myositis ossificans progressiva is a rare hereditary mesodermal disorder, It is a mutation in chromosome 2 in the bone morphogenetic protein type, receptor ACVRI, with an incidence of less than 1 in 10,000,000 populations affecting all ethnic backgrounds with both sexes equally [<xref rid="cit0001" ref-type="bibr">1</xref>]. More than 95% of cases are sporadic and comes from de novomutation. There is progressive ectopic ossification and characteristics skeletal malformations like malformations of the big toe. Ectopic bone formation occurs in the connective tissue within the muscles, fascia, tendons, ligaments and joint capsules [<xref rid="cit0002" ref-type="bibr">2</xref>]. In our case the woman does not present the malformation of the big toe. This malformation was reported in 79-100% of patients is considered pathognomonic sign [<xref rid="cit0003" ref-type="bibr">3</xref>]. Early clinical manifestation is characterized by soft tissue ossification, especially of the neck and other areas, such as those of the lower limbs and dorsum can also be affected in early clinical status [<xref rid="cit0004" ref-type="bibr">4</xref>]. The disease is characterized by frequent edemas as a result of inflammatory processes that causes ossification and, subsequently, restriction of motility of the affected region which may become painful. The women in the case discussed had no pain but his movements were apparently restricted. The diagnosis depends on the clinical and radiological demonstration of the characteristic skeletal malformation. Routine laboratory tests are usually normal or non-contributive [<xref rid="cit0005" ref-type="bibr">5</xref>]. Moreover, the severity of the disease may be underestimated by X-rays. Magnetic Resonance Imaging has a role in making the diagnosis in the early stage (preosseous stage). The preosseous lesions usually have low signal intensity on T1-weighted images and high signal intensity on T2- weighted images [<xref rid="cit0006" ref-type="bibr">6</xref>]. Bone scintigraphy with 99mTc -MDP may show early ectopic ossification and may also contribute to the evaluation of the progression and the extent of the disease [<xref rid="cit0007" ref-type="bibr">7</xref>]. If the diagnosis of MOP is clear on clinical and radiological grounds calcified nodules biopsy should be avoided because it can result in recurrent ossification of the biopsy site [<xref rid="cit0008" ref-type="bibr">8</xref>]. Exacerbation of MOP may occur in spontaneously or be precipitated by trauma, Such As by surgical operations or intramuscular injections; however they usually appear independently of extrinsic factors, with unpredictable frequency [<xref rid="cit0002" ref-type="bibr">2</xref>]. Differential diagnosis of MOP is obtained with dermatomyositis, tumoral idiopathic calcinosis, idiopathic calcinosis, and calcium metabolism diseases, Osteosarcoma but in this case it is extremely painful with a high level of alkaline phosphatase. Many treatments have been used, Corticosteroids, non-steroidal anti-inflammatory drugs but without results. In vitro chemical studies have shown that bisphosphonates adsorb hydroxyapatite crystals, thus diminishing heterotopic bone formation during the active stage of the disease [<xref rid="cit0009" ref-type="bibr">9</xref>], when there is a severe limitation on movements and gastric intolerance, use of intravenous bisphosphonate may be indicated and may produce a good improvement. However, disease progression remains unchanged.</p>
    </sec>
    <sec sec-type="conclusion" id="sec4">
      <title>Conclusion</title>
      <p>Myositis ossificans progressive must diagnosed early and noninvasivel, based on history, clinical and radiological discovery. Early and correct diagnosis is fundamental for indication of proper management of the disease. Exacerbation of the disease may occur spontaneously or be precipitated by trauma, such as by surgical operations or intramuscular injections. If the diagnosis of MOP is clear on clinical and radiological grounds the biopsy of calcified nodules should be avoided.</p>
    </sec>
  </body>
  <back>
    <sec sec-type="COI-statement">
      <title>Competing interests</title>
      <p>The authors declare no conflict of interest.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; contributions</title>
      <p>All authors contributed to the writing of this manuscript and read and approved the final version.</p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="cit0001">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Delatychi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rogers</surname>
              <given-names>JG</given-names>
            </name>
          </person-group>
          <article-title>The genetics of fibrodysplasia ossificans progressiva</article-title>
          <source>ClinOrthopRel Res</source>
          <year>1998</year>
          <volume>346</volume>
          <fpage>15</fpage>
          <lpage>18</lpage>
        </element-citation>
      </ref>
      <ref id="cit0002">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buyse</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Silberstein</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Goemans</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Casaer</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Fibrodysplasia ossificans progressiva: still turning into wood after 300 years?</article-title>
          <source>Eur J Pediatr</source>
          <year>1995</year>
          <volume>154</volume>
          <issue>9</issue>
          <fpage>694</fpage>
          <lpage>699</lpage>
          <pub-id pub-id-type="pmid">8582418</pub-id>
        </element-citation>
      </ref>
      <ref id="cit0003">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rogers</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Geho</surname>
              <given-names>WB</given-names>
            </name>
          </person-group>
          <article-title>Fibrodysplasia ossificans progressive: a survey of forty two cases</article-title>
          <source>J Bone joint Surg</source>
          <year>1979</year>
          <volume>61</volume>
          <issue>6A</issue>
          <fpage>909</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="pmid">113413</pub-id>
        </element-citation>
      </ref>
      <ref id="cit0004">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reinig</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Fang</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Marini</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zasloff</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Fibrodysplasia Ossificans Progressiva: CT Appearance</article-title>
          <source>Radiology</source>
          <year>1986</year>
          <volume>159</volume>
          <issue>1</issue>
          <fpage>153</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">3952301</pub-id>
        </element-citation>
      </ref>
      <ref id="cit0005">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shafritz</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Shore</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Gannon</surname>
              <given-names>FH</given-names>
            </name>
          </person-group>
          <article-title>Overexpression of an osteogenicmorphogen in fibrodysplasia ossificans progressiva</article-title>
          <source>N Engl J Med</source>
          <year>1996</year>
          <volume>335</volume>
          <issue>8</issue>
          <fpage>555</fpage>
          <lpage>561</lpage>
          <pub-id pub-id-type="pmid">8678932</pub-id>
        </element-citation>
      </ref>
      <ref id="cit0006">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hiroaki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Noriko</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jiro</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kazutoshi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Shigeharu</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Gen</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Contrast-Enhanced MRI of an Early Preosseous Lesion of Fibrodysplasia Ossificans Progressiva in a 21-Month-Old Boy: Case report</article-title>
          <source>AJR</source>
          <year>2003</year>
          <month>10</month>
          <volume>181</volume>
          <issue>4</issue>
          <fpage>1145</fpage>
          <lpage>1147</lpage>
          <pub-id pub-id-type="pmid">14500246</pub-id>
        </element-citation>
      </ref>
      <ref id="cit0007">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Elgazzar</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Kriss</surname>
              <given-names>VM</given-names>
            </name>
            <name>
              <surname>Gelfand</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Advanced fibrodysplasia ossificans progressiva</article-title>
          <source>ClinNucl Med</source>
          <year>1995</year>
          <volume>20</volume>
          <issue>6</issue>
          <fpage>519</fpage>
          <lpage>521</lpage>
        </element-citation>
      </ref>
      <ref id="cit0008">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Connor</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <article-title>Fibrodysplasia ossificans progressiva: the clinical features and natural history of 34 patients</article-title>
          <source>J Bone Joint Surg</source>
          <year>1982</year>
          <volume>64B</volume>
          <issue>1</issue>
          <fpage>76</fpage>
          <lpage>83</lpage>
        </element-citation>
      </ref>
      <ref id="cit0009">
        <label>9</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>McEvoy</surname>
              <given-names>GK</given-names>
            </name>
          </person-group>
          <article-title>Unclassified therapeutic agents</article-title>
          <source>American Hospital Formulary Service (AHFS) Drug Information</source>
          <year>2000</year>
          <publisher-name>Bethesda, Library of Congress</publisher-name>
          <fpage>3399</fpage>
          <lpage>403</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
